Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Ensysce Biosciences (ENSC) Long-Term Debt Issuances (2020 - 2021)

Ensysce Biosciences (ENSC) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $5.3 million as the latest value for Q3 2021.

  • On a quarterly basis, Long-Term Debt Issuances rose 2550.0% to $5.3 million in Q3 2021 year-over-year; TTM through Dec 2022 was $5.4 million, a N/A change, with the full-year FY2023 number at $1.6 million, down 78.69% from a year prior.
  • Long-Term Debt Issuances was $5.3 million for Q3 2021 at Ensysce Biosciences, up from $50000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $5.3 million in Q3 2021 to a low of -$200000.0 in Q2 2020.